The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FAVOR study

Peter Kardos,1 Ina Hagedorn-Peinz2 1Pulmonary Department, Respiratory and Sleep Medicine at Red Cross Maingau Hospital, Group Practice Allergy, Frankfurt, Germany; 2Novartis Pharma GmbH, Nuremberg, Germany Background: The objective of the FAVOR study was to evaluate the effect of indacaterol/glyco...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kardos P, Hagedorn-Peinz I
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2017-12-01
Colecção:International Journal of COPD
Assuntos:
COPD
dual-bronchodilators
FEV1
indacaterol/glycopyrronium
treatment preference
treatment satisfaction
Acesso em linha:https://www.dovepress.com/the-impact-of-indacaterolglycopyrronium-fixed-dose-combination-versus--peer-reviewed-article-COPD
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados